Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile

Tjeerd Barf, Allard Kaptein|Journal of Pharmacology and Experimental Therapeutics|2017

Cited by 366